BioSRQ


BioSRQ is a company dedicated to assisting in drug and nutraceutical product development from concept to clinic. With decades of experience in science, research, and business, they offer comprehensive services at any stage of the development process, including research, preclinical, and clinical services. Their mission is to help clients efficiently and cost-effectively advance their therapies, setting a standard for laboratories everywhere.

Industries

biotechnology
clinical-trials
consulting
pharmaceutical
product-research

Nr. of Employees

small (1-50)

BioSRQ

Sarasota, Florida, United States, North America


Products

Trimethylthiazoline (TMT) — 1 gram (Purity ≥ 90.0%)

Research-grade 2,5-dihydro-2,4,5-trimethylthiazoline supplied as a clear light-yellow liquid. Physical and handling notes: soluble in methanol, ethanol, hexane, acetone; insoluble in water. Store protected from light at 4–6°C; handle with personal protective equipment; limited toxicology information available.

Trimethylthiazoline (TMT) — 1 gram (Purity ≥ 97.0%)

Research-grade 2,5-dihydro-2,4,5-trimethylthiazoline supplied as a clear light-yellow liquid. See storage, solubility, and handling guidance as documented for other purity grades.

Trimethylthiazoline (TMT) — 5 grams (Purity ≥ 90.0%)

Research-grade 2,5-dihydro-2,4,5-trimethylthiazoline in a 5 g quantity with documented physical properties, solubility, storage, and handling instructions.

Trimethylthiazoline (TMT) — 5 grams (Purity ≥ 97.0%)

Research-grade 2,5-dihydro-2,4,5-trimethylthiazoline in a 5 g quantity at higher purity with storage and handling guidance.

Trimethylthiazoline (TMT) — 10 grams (Purity ≥ 90.0%)

Research-grade 2,5-dihydro-2,4,5-trimethylthiazoline in a 10 g quantity with physical and handling information and recommended storage conditions.

Trimethylthiazoline (TMT) — 10 grams (Purity ≥ 97.0%)

Research-grade 2,5-dihydro-2,4,5-trimethylthiazoline in a 10 g quantity at higher purity; includes solubility, storage, and handling guidance.


Services

Cellular assays to predict gastrointestinal absorption and blood–brain barrier penetrability and to evaluate transporter interactions for small molecules.

Bioavailability and pharmacokinetic/pharmacodynamic analyses across multiple administration routes using LC-MS/MS to quantify compound exposure and BBB penetration potential.

Routine ADME screening and development of customized assays for challenging molecules with rapid data turnaround and expert interpretation.

Processing of pathological specimens, histological stains, immunostaining, and image analysis/quantification using light, fluorescence, and confocal microscopy for marker detection and colocalization.

Preclinical in vivo studies using validated in-house models for Alzheimer’s disease, traumatic brain injury, Gulf War illness, and PTSD.

Identity testing and verification of incoming ingredients using mass spectrometry and in-house analytical workflows.

View All Services

Expertise Areas

  • Preclinical assay development
  • ADME / PKPD analysis
  • CNS pathology and histology
  • In vivo neurobehavioral disease models
  • Show More (4)

Key Technologies

  • LC-MS/MS
  • In vitro cellular permeability models
  • Blood–brain barrier permeability assays
  • Histological staining and immunostaining
  • Show More (4)

News & Updates

BioSRQ currently does not have any openings. You can send your name and email to be notified when they are hiring again.

An article discussing how metabolomics is advancing personalized medicine, highlighting the success of drugs like Humira.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.